PT915842E - Esteres nitratos e sua utilizacao para condicoes neurologicas - Google Patents
Esteres nitratos e sua utilizacao para condicoes neurologicasInfo
- Publication number
- PT915842E PT915842E PT97922791T PT97922791T PT915842E PT 915842 E PT915842 E PT 915842E PT 97922791 T PT97922791 T PT 97922791T PT 97922791 T PT97922791 T PT 97922791T PT 915842 E PT915842 E PT 915842E
- Authority
- PT
- Portugal
- Prior art keywords
- nitrate
- nitrate esters
- neurological conditions
- esters
- vasodilators
- Prior art date
Links
- 150000002823 nitrates Chemical class 0.000 title abstract 2
- 230000000926 neurological effect Effects 0.000 title 1
- -1 Aliphatic Nitrate esters Chemical class 0.000 abstract 2
- SIBFQOUHOCRXDL-UHFFFAOYSA-N 3-bromopropane-1,2-diol Chemical compound OCC(O)CBr SIBFQOUHOCRXDL-UHFFFAOYSA-N 0.000 abstract 1
- 229910002651 NO3 Inorganic materials 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
- 238000006396 nitration reaction Methods 0.000 abstract 1
- 125000004437 phosphorous atom Chemical group 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/11—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton
- C07C255/14—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound oxygen atoms bound to the same saturated acyclic carbon skeleton containing cyano groups and esterified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/28—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
- C07C331/02—Thiocyanates
- C07C331/10—Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/02—Thiosulfates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/658,145 US5807847A (en) | 1996-06-04 | 1996-06-04 | Nitrate esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT915842E true PT915842E (pt) | 2004-08-31 |
Family
ID=24640087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97922791T PT915842E (pt) | 1996-06-04 | 1997-05-30 | Esteres nitratos e sua utilizacao para condicoes neurologicas |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US5807847A (pt) |
| EP (1) | EP0915842B1 (pt) |
| JP (1) | JP2000511197A (pt) |
| AT (1) | ATE265427T1 (pt) |
| AU (1) | AU725046B2 (pt) |
| BR (1) | BR9709635A (pt) |
| CA (1) | CA2255824C (pt) |
| DE (1) | DE69728886T2 (pt) |
| DK (1) | DK0915842T3 (pt) |
| ES (1) | ES2219765T3 (pt) |
| PT (1) | PT915842E (pt) |
| WO (1) | WO1997046521A1 (pt) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050137191A1 (en) * | 1996-06-04 | 2005-06-23 | Thatcher Gregory R. | Nitrate esters and their use for mitigating cellular damage |
| US7115661B1 (en) * | 1999-12-29 | 2006-10-03 | Queen's University At Kingston | Methods and compositions for mitigating pain |
| US6310052B1 (en) * | 1996-06-04 | 2001-10-30 | Queen's University At Kingston | Nitrate esters and their use for neurological conditions |
| IL120531A (en) * | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
| ATE437637T1 (de) | 2001-05-02 | 2009-08-15 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
| ITMI20011307A1 (it) * | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per l'epilessia |
| US7273616B2 (en) * | 2002-05-10 | 2007-09-25 | The Trustees Of Columbia University In The City Of New York | Genetically engineered cell lines and systems for propagating Varicella zoster virus and methods of use thereof |
| EP1670459A4 (en) * | 2003-08-20 | 2009-03-25 | Nitromed Inc | NITROSED AND NITROSYLATED CARDIOVASCULAR COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS |
| CA2536975A1 (en) * | 2003-08-28 | 2005-03-17 | Nitromed, Inc. | Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| CA2554716A1 (en) * | 2004-01-22 | 2005-08-04 | Nitromed, Inc. | Nitrosated and/or nitrosylated compounds, compositions and methods of use |
| DE102004007706A1 (de) * | 2004-02-16 | 2005-08-25 | Dynamit Nobel Gmbh Explosivstoff- Und Systemtechnik | Verfahren zur Herstellung von flüssigen Nitratestern |
| US7968575B2 (en) * | 2004-05-05 | 2011-06-28 | Renopharm Ltd. | Nitric oxide donors and uses thereof |
| US7498445B2 (en) * | 2004-05-05 | 2009-03-03 | Renopharm Ltd. | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof |
| WO2005105065A2 (en) * | 2004-05-05 | 2005-11-10 | Renopharm Ltd. | Thiazole-based nitric oxide donors for treating inflammatory bowel diseases |
| US8134010B2 (en) * | 2004-05-05 | 2012-03-13 | Renopharm Ltd. | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof |
| TW200616604A (en) | 2004-08-26 | 2006-06-01 | Nicholas Piramal India Ltd | Nitric oxide releasing prodrugs containing bio-cleavable linker |
| WO2006027711A2 (en) * | 2004-08-26 | 2006-03-16 | Nicholas Piramal India Limited | Prodrugs and codrugs containing bio- cleavable disulfide linkers |
| WO2006041855A2 (en) | 2004-10-04 | 2006-04-20 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
| CA2576279A1 (en) * | 2004-11-08 | 2006-05-18 | Nitromed, Inc. | Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders |
| AU2006206249A1 (en) * | 2005-01-21 | 2006-07-27 | Nicox S.A. | Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use |
| CA2597422A1 (en) * | 2005-02-16 | 2007-08-02 | Nitromed, Inc. | Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| JP2008531697A (ja) * | 2005-02-28 | 2008-08-14 | ニトロメッド インコーポレーティッド | 酸化窒素増強基を含む心血管化合物、組成物および使用法 |
| AU2006223392A1 (en) * | 2005-03-09 | 2006-09-21 | Nicox S.A. | Organic nitric oxide enhancing salts of angiotensin II antagonists, compositions and methods of use |
| US20090075956A1 (en) * | 2005-04-07 | 2009-03-19 | Nitromed, Inc. | Genetic Risk Assessment in Heart Failure: Impact of the Genetic Variation of NOS3 |
| WO2006127591A2 (en) * | 2005-05-23 | 2006-11-30 | Nitromed, Inc. | Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| US20090018091A1 (en) * | 2005-08-02 | 2009-01-15 | Nitromed, Inc. | Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use |
| AU2006299382A1 (en) * | 2005-10-04 | 2007-04-12 | Nitromed, Inc. | The genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic receptor Gly389Arg polymorphism |
| WO2007059311A2 (en) * | 2005-11-16 | 2007-05-24 | Nitromed, Inc. | Furoxan compounds, compositions and methods of use |
| WO2007075541A2 (en) * | 2005-12-20 | 2007-07-05 | Nitromed, Inc. | Nitric oxide enhancing glutamic acid compounds, compositions and methods of use |
| US20080293702A1 (en) * | 2005-12-22 | 2008-11-27 | Nitromed, Inc. | Nitric Oxide Enhancing Pyruvate Compounds, Compositions and Methods of Use |
| CA2647859C (en) * | 2006-03-29 | 2016-01-05 | Nitromed, Inc. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| CA2646266A1 (en) * | 2006-04-10 | 2007-10-25 | Nitromed, Inc. | Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphism |
| US20090182011A1 (en) * | 2008-01-16 | 2009-07-16 | University Of Illinois Chicago | Chimeric Nitrate Esters and Use of the Same in a Treatment for Depression |
| US7807716B2 (en) * | 2008-09-24 | 2010-10-05 | Oral Delivery Technology Ltd. | Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use |
| HUE037163T2 (hu) | 2009-06-09 | 2018-08-28 | Prolong Pharmaceuticals Llc | Hemoglobin készítmények |
| CN103833723B (zh) * | 2009-08-04 | 2016-08-17 | 和光纯药工业株式会社 | 环状磺酸酯的制造方法及其中间体 |
| CN102883610A (zh) | 2010-02-12 | 2013-01-16 | 默沙东公司 | 二醇二氮烯*环戊基衍生物 |
| AU2011248124B2 (en) | 2010-05-05 | 2016-07-21 | The Board Of Trustees Of The University Of Illinois | Compounds and methods of treating brain disorders |
| EP2571351B1 (en) | 2010-05-21 | 2016-09-14 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
| MX2013004739A (es) | 2010-10-29 | 2013-07-02 | Merck Sharp & Dohme | Derivados heterociclicos de diazenodiolato. |
| JO3350B1 (ar) | 2011-03-07 | 2019-03-13 | Merck Sharp & Dohme | مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات |
| US9272987B2 (en) | 2011-05-02 | 2016-03-01 | Merck Sharp & Dohme Corp. | Diazeniumdiolate cyclohexyl derivatives |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA764461A (en) * | 1967-08-01 | Fink Walter | Metallorganic halonitrates | |
| CA792246A (en) * | 1968-08-13 | Muhlbauer Ernst | Process for the preparation of substituted 1,3-oxathiol-2-ones | |
| JPS51125750A (en) * | 1974-09-17 | 1976-11-02 | Rikagaku Kenkyusho | Agermicide for agricuture and gardening |
| DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3512627A1 (de) * | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
| JPH0726949B2 (ja) * | 1988-06-01 | 1995-03-29 | 住友化学工業株式会社 | 抽出溶媒の劣化度測定方法 |
| JP2628756B2 (ja) * | 1988-09-15 | 1997-07-09 | シュバルツファルマ アクチェンゲゼルシャフト | 新規有機ニトレート及びそれらの製造方法 |
| NL8802276A (nl) * | 1988-09-15 | 1990-04-02 | Cedona Pharm Bv | Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat. |
| US5428061A (en) * | 1988-09-15 | 1995-06-27 | Schwarz Pharma Ag | Organic nitrates and method for their preparation |
| US5284872A (en) * | 1989-09-12 | 1994-02-08 | Schwarz Pharma Ag | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof |
| DE4011505C2 (de) * | 1990-04-10 | 1995-01-12 | Sanol Arznei Schwarz Gmbh | Nitratoalkancarbonsäure-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE4004841A1 (de) * | 1990-02-16 | 1991-08-22 | Boehringer Mannheim Gmbh | Salpetersaeureester von cyclohexanol-derivaten |
| US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
| CA2158368A1 (en) * | 1993-03-15 | 1994-09-29 | Jan Bron | Use of substituted alkyl nitrates for the treatment of pathologically raised intraocular pressure |
| DE4321306A1 (de) * | 1993-06-26 | 1995-01-05 | Sanol Arznei Schwarz Gmbh | Disulfide |
-
1996
- 1996-06-04 US US08/658,145 patent/US5807847A/en not_active Expired - Fee Related
-
1997
- 1997-05-30 EP EP97922791A patent/EP0915842B1/en not_active Expired - Lifetime
- 1997-05-30 PT PT97922791T patent/PT915842E/pt unknown
- 1997-05-30 WO PCT/CA1997/000372 patent/WO1997046521A1/en not_active Ceased
- 1997-05-30 ES ES97922791T patent/ES2219765T3/es not_active Expired - Lifetime
- 1997-05-30 BR BR9709635A patent/BR9709635A/pt not_active Application Discontinuation
- 1997-05-30 AT AT97922791T patent/ATE265427T1/de not_active IP Right Cessation
- 1997-05-30 AU AU28839/97A patent/AU725046B2/en not_active Ceased
- 1997-05-30 DE DE69728886T patent/DE69728886T2/de not_active Expired - Fee Related
- 1997-05-30 JP JP10500039A patent/JP2000511197A/ja not_active Ceased
- 1997-05-30 DK DK97922791T patent/DK0915842T3/da active
- 1997-05-30 CA CA002255824A patent/CA2255824C/en not_active Expired - Fee Related
- 1997-06-03 US US08/867,856 patent/US5883122A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR9709635A (pt) | 1999-08-10 |
| US5883122A (en) | 1999-03-16 |
| CA2255824C (en) | 2006-01-24 |
| AU725046B2 (en) | 2000-10-05 |
| AU2883997A (en) | 1998-01-05 |
| JP2000511197A (ja) | 2000-08-29 |
| US5807847A (en) | 1998-09-15 |
| DE69728886D1 (de) | 2004-06-03 |
| DK0915842T3 (da) | 2004-07-26 |
| EP0915842B1 (en) | 2004-04-28 |
| EP0915842A1 (en) | 1999-05-19 |
| CA2255824A1 (en) | 1997-12-11 |
| ES2219765T3 (es) | 2004-12-01 |
| ATE265427T1 (de) | 2004-05-15 |
| WO1997046521A1 (en) | 1997-12-11 |
| DE69728886T2 (de) | 2005-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT915842E (pt) | Esteres nitratos e sua utilizacao para condicoes neurologicas | |
| DE3364718D1 (en) | Arachidonic acid analogues as anti-inflammatory and antiallergic agents | |
| PT89109A (pt) | Metodo para melhorar a funcao cognitiva por administracao de d-ciclosserina e suas pro-drogas | |
| AU572549B2 (en) | 1-benzoyl-3-phenyl-urea derivatives | |
| DK0659174T3 (da) | Derivater af valproinsyre og 2-valproensyreamider samt deres anvendelse som antikonvulsive midler | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| BG31462A3 (bg) | Метод за получаване на 1-винилтриазолови производни както и тяхното приложение като регулатори на растежа и фунгицидни средства | |
| EP0310070A3 (en) | Alpha-aminoacyl beta-aminoacyl aminodiols as anti-hypertensive agents | |
| BG32262A3 (en) | Means for plant requlation | |
| BG50163A3 (bg) | Метод за получаване на ацилови производни | |
| ES500295A0 (es) | Metodo para el cultivo de microorganismos | |
| BR8803485A (pt) | Derivados de hidroxialquil-azolila,processo para sua preparacao,composicoes fungicidas,aplicacao,oxiranas,processo para sua preparacao,ciclopropil-cetonas,processo para sua preparacao,carbinois,processo para sua preparacao | |
| IT7949883A0 (it) | Ne detto prodotto procedimento per la sintesi enzimatica di un rna a doppio filamento prodotto ottenuto e composizione induttrice di interferone che contie | |
| DE3578687D1 (de) | N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung. | |
| ES8300094A1 (es) | "un procedimiento para preparar derivados de halofenil-piridil-alilamina". | |
| BG35184A3 (en) | Means and method for growth regulation of plants | |
| ES2073370A1 (es) | Procedimiento para la preparacion del compuesto bis-(1,3-dihidroxi-propilamida) del acido l-5-(2-acetoxi-propionilamino)-2,4,6-triyodo-isoftalico. | |
| ES8707193A1 (es) | Un metodo para producir derivados de bromodicloroimidazol | |
| BG36625A3 (en) | Herbecide antidote means and method for protection fpom unwanted growth | |
| IT1207249B (it) | Uso di derivato metacrilammidico come catalizzatore per poliuretani. | |
| EP0331105A3 (en) | 1,2-hydroxy phosphonates and derivatives thereof | |
| ATE106871T1 (de) | Pyridinderivate und verfahren zu ihrer synthese. | |
| CA2078697A1 (en) | Imine compounds and their production | |
| ES2129839T3 (es) | Derivados de benzoilo y su sintesis. | |
| BG33432A3 (en) | Means and method for plant growth regulation |